INHIBITOR FOR THE ONSET AND PROGRESS OF LIVER CANCER TO BE USED IN HEPATITIS C VIRUS-POSITIVE HUMAN LIVER CIRRHOSIS PATIENTS

摘要

The present invention provides, as a pharmaceutical agent having an effect to inhibit the development and/or progression of liver cancer in hepatitis C virus-positive human cirrhosis patients, an agent for inhibiting the development and/or progression of liver cancer in hepatitis C virus-positive human cirrhosis patients, which contains three kinds of amino acids of isoleucine, leucine and valine.